Incidence of preexisting B-cell aplasia in B-ALL: implications for post-CAR T-cell monitoring
Blood Adv
.
2024 Dec 24;8(24):6329-6333.
doi: 10.1182/bloodadvances.2024014641.
Authors
Isha Sahai
1
,
Paul Borgman
1
,
Bonnie Yates
1
,
Sergio Rosenzweig
2
,
Shakuntala Rampertaap
2
,
Alexander W Rankin
1
,
Nirali N Shah
1
Affiliations
1
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
2
Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
PMID:
39454282
DOI:
10.1182/bloodadvances.2024014641
No abstract available